Luo Yuanyuan, Shang Pingping, Li Dongye
The First Clinical College, Nanjing University of Chinese Medicine, Nanjing, China.
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Front Pharmacol. 2017 Oct 6;8:692. doi: 10.3389/fphar.2017.00692. eCollection 2017.
Cardiovascular disease (CVD) has become the leading cause of morbidity and mortality worldwide. A well-monitored diet with a sufficient intake of fruits and vegetables has been confirmed as a primary prevention of CVD. Plant constituents such as flavonoids have been shown to confer healthy benefits. Luteolin (Lut), a kind of flavonoid, possesses anti-oxidative, anti-tumor, and anti-inflammatory properties. Recent scientific literature has reported the cardiac protective effects of Lut and . Therefore, the aim of this review is to provide an update and detailed overview with cardio-protective molecular mechanisms of Lut with a focus on multiple intrinsic and extrinsic effectors. We further explore how these mechanisms participate in ischemia/reperfusion (I/R) injury, heart failure (HF) and atherosclerosis (AS). A proper understanding of the cardiovascular protective effects and the relative mechanisms of Lut may provide the possibility of new drug design and development for CVD. With the previous studies mainly focused on basic research, we need to advance the prospects of its further clinical utilization against CVD, large prospective clinical trials of Lut are needed to observe its therapeutic effects on patients with I/R injury, HF and AS, especially on the effective therapeutic dosage, and safety of long-term administration.
心血管疾病(CVD)已成为全球发病和死亡的主要原因。经充分摄入水果和蔬菜的良好监测饮食已被确认为心血管疾病的一级预防措施。黄酮类化合物等植物成分已被证明具有健康益处。木犀草素(Lut)是一种黄酮类化合物,具有抗氧化、抗肿瘤和抗炎特性。最近的科学文献报道了Lut的心脏保护作用。因此,本综述的目的是提供Lut心脏保护分子机制的最新详细概述,重点关注多种内在和外在效应器。我们进一步探讨这些机制如何参与缺血/再灌注(I/R)损伤、心力衰竭(HF)和动脉粥样硬化(AS)。正确理解Lut的心血管保护作用及其相关机制可能为心血管疾病的新药设计和开发提供可能性。由于先前的研究主要集中在基础研究上,我们需要推进其在心血管疾病临床应用中的前景,需要进行大规模的前瞻性临床试验,观察Lut对I/R损伤、HF和AS患者的治疗效果,特别是有效治疗剂量和长期给药的安全性。